Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?

Hepatology (Baltimore, Md.)

Volumn 38, Issue 6, 2003, Pages 1584-1587

  Aloman, Costica ^a   Wands, Jack R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; LAMIVUDINE; P PROTEIN, HEPATITIS B VIRUS; PHOSPHONIC ACID DERIVATIVE; POL PROTEIN; VIRUS DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD; DRUG COMBINATION; DRUG EFFECT; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; MUTATION;

ADENINE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; GENE PRODUCTS, POL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; LAMIVUDINE; MUTATION; PHOSPHONIC ACIDS;

EID: 0642374132     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510380633     Document Type: Article

References (0)